Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Galaxa Pharma a/s
A/S
Active
Advertising protection
CVR 41183144
Indiakaj 10, 2100
København Ø
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2020 · 6 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Galaxa Pharma a/s
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2021
-1M
2022
-2M
2023
-1M
2024
0M
2025
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
0M
2021
-2M
-200%
2022
-2M
0%
2023
-1M
+50%
2024
0M
+100%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
666
-846
-1.971
-898
-399
Staff expenses
-194
-1.602
-13
-2
-0
EBITDA
-200
-2.448
-1.959
-900
-399
Depreciation & amort.
-0
-113
-113
-113
-4
EBIT
-200
-2.561
-2.072
-1.013
-403
Net financials
-2
-143
-77
-71
-35
Profit before tax
-202
-2.704
-2.149
-1.084
-438
Tax
-68
-658
-406
-264
23
Net profit
-134
-2.046
-1.743
-820
-461
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
3.380
3.074
2.584
1.598
1.402
Equity
360
814
572
252
-210
Long-term debt
0
0
0
0
0
Short-term debt
3.020
2.260
2.012
1.347
1.612
Total debt
3.020
2.260
2.012
1.347
1.612
Financial ratios
5-year trend
EBITDA margin
-39887400.0%
This company
15.8%
Market median
-252451999% vs market
2021
2025
Equity ratio
-14.9%
This company
38.2%
Market median
-139% vs market
2021
2025
Return on equity
-46128100.0%
This company
18.4%
Market median
-250696296% vs market
2021
2025
Net profit margin
-46128100.0%
This company
8.1%
Market median
-569482816% vs market
2021
2025
Asset turnover
-0.28×
This company
1.12×
Market median
-125% vs market
2021
2025
Debt / equity
7.69×
This company
0.62×
Market median
-1140% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on Galaxa Pharma a/s
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
